Welcome to our dedicated page for Rentokil Initial Plc SEC filings (Ticker: RTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Rentokil Initial plc (NYSE: RTO) provides access to the company’s U.S. regulatory disclosures, including its annual report on Form 20-F and current reports on Form 6-K. As a foreign private issuer and UK-listed company, Rentokil Initial uses these filings to share information with U.S. investors about its global pest control, hygiene and wellbeing operations.
Form 20-F contains detailed information about the group’s business activities, risk factors, governance and financial reporting. For a company operating in around 90 countries and employing more than 60,000 people, this document is a key resource for understanding the structure and scope of its pest control and hygiene services, as well as its North American operations under the Rentokil Terminix brand.
Form 6-K current reports are used to furnish important information that Rentokil Initial releases in other markets. Examples in the available data include notifications of major shareholdings, directorate changes and announcements that the Annual Report and Financial Statements and AGM notices have been filed with the UK Financial Conduct Authority and made available via the National Storage Mechanism. Some 6-K filings also cover matters such as director and related party share dealings in the company’s American Depositary Shares.
On Stock Titan, these filings are updated as they are released through EDGAR and can be paired with AI-powered summaries to help explain complex sections in clearer language. This can be particularly useful when reviewing topics such as major shareholder notifications, governance changes or the structure of Rentokil Initial’s ADS programme, where each ADS represents five ordinary shares. The filings page is therefore a central reference point for investors and researchers seeking a regulatory view of RTO’s global business services operations.
Rentokil Initial plc has set the sterling amount for its previously announced final dividend for the year ending 31 December 2025 at 6.10 pence per ordinary share. The dividend was originally declared as 8.24 cents per share, and the conversion uses an exchange rate of GBP1:USD1.3513 based on the average closing spot rates over three working days starting 20 April 2026.
The final dividend remains subject to shareholder approval at the Annual General Meeting on 7 May 2026. If approved, it will be paid on 18 May 2026 to shareholders on the register at the close of business on 10 April 2026.
Rentokil Initial plc, through wholly owned subsidiary Rentokil Terminix Funding plc, has issued senior, unsecured $500 million 4.625% Notes due 2031, guaranteed by the Company. The notes were offered to qualified institutional buyers under Rule 144A and outside the U.S. under Regulation S.
The Company intends to use the net proceeds for general corporate purposes, including debt repayment. Application has been made to list and trade the notes on the Official List and Global Exchange Market of Euronext Dublin.
Rentokil Initial plc reports a TR‑1 notification of major holdings from BlackRock, Inc.. BlackRock’s total holding in Rentokil Initial now represents 13.000000% of voting rights, up from 12.510000% at the previous notification, corresponding to 328889348 voting rights held in the issuer.
The position is split between voting rights attached to shares and financial instruments. Shares carry 263877846 voting rights, equal to 10.440000%. Financial instruments provide an additional 2.560000% of voting rights, including American Depository Receipts and securities lending arrangements, as well as contracts for difference and equity‑linked notes.
Rentokil Initial plc reported first-quarter 2026 revenue of $1,677m, up 4.3% at constant currency with 3.4% Organic Revenue growth. Management described this as a good start in a seasonally quieter period and expressed confidence in delivering a full-year performance in line with market expectations.
North America generated revenue of $995m, up 4.5%, with Pest Control growing organically by 4.1% and strong 12.7% Organic Revenue growth in Business Services helped by pre-spring demand and prior-year contract wins. International revenue was $682m, up 4.1%, with good growth in Europe, Latin America and the UK & Sub-Saharan Africa, partly offset by softer trends in Pacific and MENAT.
By category, Pest Control delivered 3.7% Organic Revenue growth, while Hygiene & Wellbeing grew 2.1% overall, including a decline of (2.7)% organically in North America due to later construction-related revenue. The Group completed 9 bolt-on acquisitions with prior-year annualised revenue of $19m, continuing its M&A-led expansion strategy.
Rentokil Initial plc has appointed Thérèse Esperdy as Chair of the Board, effective 1 September 2026. She will first join as a Non-Executive Director and Chair-designate on 1 July 2026, supporting an orderly transition.
Esperdy currently serves as Non-Executive Chair of Imperial Brands and holds senior roles at Smith & Nephew and Moody's, with a long executive background at JP Morgan. She will receive total fees of £725,000 per annum. Current Chair Richard Solomons, who has led the Board since 2019, will retire from the Board at midnight on 31 August 2026. The Board has determined Esperdy to be independent under the Corporate Governance Code.
Rentokil Initial plc has reported a change in a major shareholding by BlackRock, Inc.. BlackRock now holds a total of 12.51% of Rentokil Initial’s voting rights, equivalent to 316,885,253 voting rights.
The position consists of 10.05% of voting rights attached to ordinary shares and a further 2.46% held through financial instruments such as American Depositary Receipts, securities lending and derivatives. The total stake increased slightly from a previously notified 12.33%, indicating a modest rise in BlackRock’s exposure to the company.
Rentokil Initial plc reported that its Chair, Richard Solomons, who is classified as a Person Discharging Managerial Responsibility, bought additional shares in the company. On 26 March 2026, he purchased 21,100 ordinary shares at a price of £4.635902 per share, for a total consideration of £97,817.53. The transaction involved ordinary shares of 1p each, traded on the London Stock Exchange (XLON), and was disclosed in line with Article 19 of the UK Market Abuse Regulation.
Rentokil Initial plc filed its 2025 Form 20‑F, providing a comprehensive overview of its global pest control and hygiene operations. The group prepares financials under IFRS and lists American Depositary Shares on the NYSE, with each ADS representing five ordinary shares.
As of 31 December 2025, Rentokil Initial had 2,526,039,885 ordinary shares outstanding, 63,388 colleagues and 2,081 facilities across 90 countries. The company highlights an acquisition‑led growth strategy, noting 36 businesses acquired in 2025 and the disposal of its French Workwear business completed on 30 September 2025.
Extensive risk disclosures cover integration challenges, heavy reliance on skilled labour, inflation and macroeconomic pressures, ESG expectations, and cyber security. The group reports ten cyber security incidents in 2025, all handled without material business impact. It also details substantial termite‑related damage claims, with additional provisions of $201 million and a closing provision of $384 million, alongside total outstanding indebtedness of approximately $6.1 billion and related covenant and ratings risks.
Rentokil Initial plc reported that Non-Executive Director and Person Discharging Managerial Responsibility Sally Johnson bought ordinary shares in the company. On 16 March 2026, she purchased 2,676 ordinary shares at a price of £4.828995 per share, for a total of £12,922.39.
The shares are ordinary shares of 1p each, identified by ISIN GB00B082RF11, and the transaction took place on the London Stock Exchange (XLON). The disclosure is made in line with Article 19 of the UK Market Abuse Regulation.
Rentokil Initial plc reported that investor BlackRock, Inc. has crossed a major shareholding threshold, with a total of 12.330000% of the company’s voting rights. This represents 312131771 voting rights in aggregate.
The position includes 9.910000% of voting rights attached to ordinary shares, representing 250562761 voting rights. A further portion is held through financial instruments, including American Depository Receipts and securities lending positions, plus contracts for difference and equity-linked notes, giving BlackRock exposure to additional voting rights in Rentokil Initial.